Oxford Science Enterprises
Overview
Oxford Science Enterprises is an independent investment company and venture builder that partners with the University of Oxford to found, fund, and build businesses in the life sciences, health technology, and deep technology sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| RQ Biotechnology Limited | Jun 2026 | Series A | Co-investor |
| Applied Atomics | Jun 2026 | Pre Seed | Lead |
| Applied Atomics | Jun 2026 | Pre Seed | Lead |
| Oxford Quantum Circuits | Jun 2026 | Series C | Co-investor |
| Caudal Energy | May 2026 | VC Round | Lead |
Key People
Craig Fox
Operating Partner (Lifesciences)
Scott Ellis
Scientific Operating Partner
Claire Brown
Partner ( Life Sciences)
Nick Dixon-Clegg
Partner
Sam Harman
Partner, Head Of Deep Tech
Sanne de Jongh
VC Partner
Polly Elvin
Head Of Investor Relations And Co-investors
George Todd
Principal
Joel Schoppig
Principal
Liliane Chamas
Healthtech Principal
Oliver Mahony
Principal
Richard Oakley
Principal
Sally Dewhurst
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
